FDA clears St. Jude's intracardiac echo catheter

| | Health Imaging | Screening
St. Jude Medical received 510(k) clearance from the FDA for the ViewFlex Xtra Intracardiac Echocardiography (ICE) catheter.

The catheter technology is designed to be used with the ViewMate Z Ultrasound console, a system that provides images to visualize cardiac structures and blood flow within the heart during electrophysiology or interventional procedures, the St. Paul, Minn.-based company said in a release. The ViewFlex ICE catheter has a new handle, allowing for single-handed, four-way tip deflection and self-locking steering. 



Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.